← Leaderboards
Ethel Siris
Columbia University Health Sciences
$749,324
Attributed
$749,324
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$749,324 · 4
By mechanism
M01$749,324 · 4
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Pamela U Freda$13,039,453
- Robert E Canfield$431,855
- Maya Mikami$821,190
- Jean E Mulder$515,373
- Francis Young-In Lee$14,507,034
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectDrug Screening /EvaluationSkeletal Disorder ChemotherapyWomen'S HealthBone FractureDrug Adverse EffectFemaleOsteoporosisPostmenopausePiperidineCalciumBone DensityEstrogen InhibitorOsteitis DeformansIntravenous AdministrationTransdermal Drug DeliveryPhysiologic Bone ResorptionPlacebosBiomarkerDisease /Disorder Proneness /RiskDosageDiphosphonate
Grant awards (8)
RALOXIFENE$192,910
M01 · FY2002 · RR
RALOXIFENE$192,910
M01 · FY2001 · RR
RALOXIFENE$0
M01 · FY2001 · RR
1 25 &2 5MG OF LEVORMELOXIFENE VS PLACEBO FOR TREAT OF POSTMENOP OST$121,168
M01 · FY2000 · RR
ZOLEDRONATE IN PAGET'S DISEASE$121,168
M01 · FY2000 · RR
OUTPATIENT AREDIA INFUSIONS IN PAGETS DISEASE$121,168
M01 · FY2000 · RR
RALOXIFENE$0
M01 · FY2000 · RR
RALOXIFENE$0
M01 · FY2000 · RR